V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009573 | 190006200 | 1.6 | 94 | Palliative (P) | 2019-01-16 | 2019-02-04 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100290138 |
| 190009576 | 190006201 | 1.86 | 60.8 | Curative (C) | 2018-05-13 | 2018-05-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101692741 |
| 190009580 | 190006202 | 1.5 | 41.8 | null | 2019-01-27 | 2019-01-28 | OST Mifamurtide | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101149101 |
| 190009586 | 190006203 | 1.67 | 64 | null | 2018-05-12 | 2018-06-05 | GemCarbo Days 1+8 | 02 | null | EW EUROEWING 2012 ARM A VAI | 100381543 |
| 190009596 | 190006204 | 1.68 | 58 | Palliative (P) | 2021-08-04 | 2021-08-04 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101696932 |
| 190009601 | 190006205 | 1.47 | 89.8 | null | 2021-03-25 | 2021-04-14 | Capecitabine (21 day) + Irinotecan | 02 | N | CYTARABINE + FLUDARABINE | 100331644 |
| 190009602 | 190006206 | 1.57 | 63.4 | null | 2016-02-29 | 2016-03-28 | null | 02 | N | EW REL REECUR | 101469071 |
| 190009605 | 190006207 | 1.73 | 85 | Curative (C) | 2016-02-27 | 2016-08-27 | Irinotecan + Modified De Gramont | 02 | Y | IMATINIB | 101617699 |
| 190009610 | 190006208 | 1.46 | 30.6 | Curative (C) | 2019-01-25 | 2019-01-28 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100120986 |
| 190009614 | 190006209 | 0 | 35.1 | 03 | 2017-06-10 | 2017-06-10 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | ETOPOSIDE | 100647864 |
| 190009619 | 190006210 | 0 | 15 | Palliative (P) | 2018-12-02 | 2018-12-24 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | EW EUROEWING 2012 ARM A VAI | 100675442 |
| 190009636 | 190006211 | 1.65 | 108.6 | Palliative (P) | 2020-02-05 | 2020-08-20 | Carboplatin + Etoposide iv&po | 02 | null | STS RHABDO RMS 2005 2ND TOPO CYCLO | 100342245 |
| 190009640 | 190006212 | 1.13 | 71.6 | Curative (C) | 2016-03-11 | 2016-11-19 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100761425 |
| 190009650 | 190006213 | 1.75 | 93.3 | Palliative (P) | 2019-05-26 | 2019-05-27 | CAPECITABINE + IRINOTECAN | 02 | null | CYCLOPHOSPHAMIDE | 101732192 |
| 190009651 | 190006214 | 0 | 48.6 | Curative (C) | 2016-09-26 | 2016-09-26 | PAM x 2 post-surgery (cycles 3&4) | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101343658 |
| 190009655 | 190006215 | 1.78 | 81.5 | null | 2019-10-18 | 2019-11-02 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101178161 |
| 190009658 | 190006216 | null | 103.8 | null | 2018-10-28 | 2018-11-23 | Docetaxel | 02 | null | CISPLATIN + DOXORUBICIN | 101249931 |
| 190009668 | 190006217 | 1.15 | 77.6 | Curative (C) | 2020-02-13 | 2020-02-18 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100473939 |
| 190009681 | 190006218 | 1.8 | 34 | Palliative (P) | 2017-03-04 | 2017-03-04 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101583126 |
| 190009697 | 190006219 | null | null | Curative (C) | 2020-10-29 | 2021-01-16 | Cyclophosphamide + Vincristine | 01 | null | EW REL REECUR GEMCITABINE/DOCETAXEL | 101837941 |
| 190009698 | 190006220 | 1.6 | 57 | Neo-adjuvant (N) | 2020-06-12 | 2020-06-23 | EW EuroEwing 2012 Arm B VC | N | N | EW EUROEWING 2012 ARM B VC | 101702252 |
| 190009699 | 190006221 | 1.74 | 47 | Palliative (P) | null | 2016-04-14 | OST Euramos 1 Closed Trial - M | 01 | null | OST M | 101276424 |
| 190009714 | 190006222 | 1.8 | 93 | Adjuvant (A) | 2020-08-18 | 2020-11-09 | PAM x 2 post-surgery (cycles 3&4) | 01 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100693857 |
| 190009718 | 190006223 | 1.49 | 60.7 | null | 2018-04-18 | 2018-05-08 | LANREOTIDE | N | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101486306 |
| 190009726 | 190006224 | 1.68 | 67.4 | Neo-adjuvant (N) | 2016-10-15 | 2017-05-30 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100301166 |
| 190009733 | 190006225 | 1.65 | 97.9 | null | 2017-05-03 | 2017-06-14 | METHOTREXATE | 02 | null | METHOTREXATE | 101188031 |
| 190009739 | 190006226 | 0 | 37.4 | Palliative (P) | 2017-09-26 | 2018-03-10 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100941460 |
| 190009744 | 190006227 | 1.76 | 64 | Curative (C) | 2016-04-20 | 2016-06-02 | VINORELBINE | 02 | N | TRIAL | 100054242 |
| 190009746 | 190006228 | 1.86 | 40 | null | 2021-08-19 | 2021-09-13 | Carboplatin + Etoposide iv&po | 02 | null | DHAP | 100319042 |
| 190009749 | 190006229 | 1.8 | 82.6 | null | 2020-01-20 | 2020-02-04 | PAM x 2 post-surgery (cycles 3&4) | 01 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101016451 |
| 190009761 | 190006231 | 1.52 | 32.3 | Curative (C) | 2018-03-12 | 2018-04-06 | EW EuroEwing 2012 Arm B IE | 01 | N | EW EUROEWING 2012 ARM B IE | 100077199 |
| 190009768 | 190006232 | 1.74 | 105.2 | Palliative (P) | 2021-06-04 | 2021-06-05 | Paclitaxel 7 day | 02 | N | VIDE | 101135474 |
| 190009770 | 190006233 | 1.57 | 62.5 | Adjuvant (A) | 2017-12-12 | 2017-12-12 | Gemcitabine weekly | 02 | null | IFOSFAMIDE | 101800305 |
| 190009779 | 190006234 | 1.78 | 70.6 | Palliative (P) | 2021-05-22 | 2021-07-29 | OST Euramos 1 Closed Trial - AP | 02 | null | EW EUROEWING 2012 ARM A VAI | 100310566 |
| 190009780 | 190006235 | 1.68 | 45.3 | Palliative (P) | 2018-06-02 | 2018-06-13 | Cetuximab + Radiotherapy Maint | 02 | null | DOXORUBICIN + METHOTREXATE | 100020687 |
| 190009784 | 190006236 | 0 | 48.5 | null | 2014-01-09 | 2016-09-16 | Docetaxel 75mg/m2 (21 day) | 02 | Y | CAPECITABINE + MITOMYCIN | 100891391 |
| 190009788 | 190006237 | 1.67 | 17.8 | null | 2019-07-17 | 2019-08-15 | Cyclophosphamide High Dose | 2 | N | NOT MATCHED | 100428625 |
| 190009801 | 190006238 | 1.5 | 45 | Palliative (P) | 2021-04-27 | 2021-06-07 | ETOPOSIDE | 02 | null | EW EUROEWING 2012 ARM A VAC | 101205250 |
| 190009811 | 190006239 | 1.72 | 50 | Neo-adjuvant (N) | 2017-11-17 | 2017-12-09 | VAI (Ifos 3g/m2) | 01 | null | CETUXIMAB + RT | 100797259 |
| 190009815 | 190006240 | 1.74 | 73.2 | Neo-adjuvant (N) | 2019-09-09 | 2020-03-24 | OST Euramos 1 Closed Trial - M | N | N | OST M | 101573241 |
| 190009824 | 190006241 | 1.8 | 76 | null | 2017-11-12 | 2018-04-14 | CARBOPLATIN + ETOPOSIDE | 02 | N | EW EUROEWING 2012 ARM B VDC/IE | 101041721 |
| 190009840 | 190006242 | 1.79 | 101.2 | null | 2018-06-28 | 2018-08-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DINUTUXIMAB BETA | 100295606 |
| 190009842 | 190006243 | 1.71 | 11 | null | 2017-06-21 | 2017-09-18 | EW EuroEwing 2012 Arm A VAI | Y | N | IFOSFAMIDE | 100070652 |
| 190009843 | 190006244 | 1.6 | 79.7 | Curative (C) | null | 2017-07-17 | Irinotecan + Temozolomide | 02 | null | TRIAL | 101154844 |
| 190009854 | 190006245 | null | 90.5 | Palliative (P) | 2016-11-07 | 2016-11-07 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100000105 |
| 190009857 | 190006246 | 1.72 | 68.3 | null | 2016-06-01 | 2016-06-01 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100491230 |
| 190009865 | 190006247 | 1.7 | 92.3 | 03 | 2021-05-27 | 2021-06-14 | PAM x 2 pre-surgery (cycles 1&2) | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100326896 |
| 190009878 | 190006248 | 0 | 61.7 | Palliative (P) | 2019-04-19 | 2019-05-09 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100482626 |
| 190009881 | 190006249 | 0 | 77.7 | Curative (C) | 2019-09-04 | 2019-11-26 | Methotrexate High Dose (3g/m2) | Y | N | METHOTREXATE | 101302257 |
| 190009882 | 190006250 | 1.81 | 25.8 | Curative (C) | 2018-09-15 | 2018-09-29 | Carboplatin + Etoposide IV 3 day | 02 | Y | STS RHABDO RMS 2005 2ND TOPO CYCLO | 101714439 |